Long-term control of cardiovascular risk factors and sustained clinical remission help to mitigate the higher risk for ...

An extension trial revealed that long-term anifrolumab treatment improved health status and health-related quality of life in ...

Lupus is a rare autoimmune disease characterized by chronic inflammation. It presents in four main forms: systemic lupus ...

This mysterious autoimmune disease presents with over 100 different symptoms, making diagnosis incredibly challenging for ...

A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...

The US Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to AbelZeta ...

Rawlings, the Member of Parliament (MP) for Korle Klottey, has expressed commitment to leading a strong advocacy in getting ...

Since joining the Lupus Research Alliance (LRA) in 2015, Albert T. Roy has risen to the role of president and CEO. During ...

Lupus Awareness Month shines a spotlight on a disease that affects millions worldwide yet remains widely misunderstood. Lupus ...

Progentec Diagnostics, a leader in advanced diagnostics and digital health solutions for autoimmune conditions, today announced breakthrough findings from its virtual lupus classification study at the ...

Procalcitonin levels greater than 0.9 ng/mL may be a useful biomarker for identifying bacterial infections among febrile patients with JSLE.

Patients who develop LN within 1 to 5 years after SLE onset may face poorer renal outcomes compared with those who develop the disease earlier.